EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multiplex Immunofluorescence Assay with Opal Reagents for Identifying Mononuclear Cell Subsets in Kidney Allograft Rejection Types

Ernest Kwame Adjepong-Tandoh, Jin-Myung Kim, Hye Eun Kwon, Youngmin Ko, Joo Hee Jung, Young Hoon Kim, Heounjeong Go iD, Haeyon Cho, Sang-Yeob Kim, Yeon-Mi Ryu, Sung Shin, Hyunwook Kwon iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ernest Kwame Adjepong-Tandoh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Korle Bu Teaching Hospital, Accra P.O. Box KB-77, Ghana. Hauptthemen laut MEDLINE: Graft Rejection, Kidney Transplantation, Fluorescent Antibody Technique, Leukocytes, Mononuclear. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibody-mediated rejection (ABMR) remains a leading cause of kidney allograft failure, yet the mechanistic roles of innate immune cell subsets such as monocytes and natural killer (NK) cells remain incompletely understood. In this retrospective cohort study, we applied OPAL-based multiplex immunofluorescence (mIF) to human kidney allograft biopsies from 38 recipients with biopsy-proven ABMR (n = 19), T-cell-mediated rejection (TCMR, n = 12), or no rejection (NR, n = 7), enabling spatially resolved quantification of immune subsets in situ. Fluorescence thresholds were pathologist-validated, and co-expression phenotypes were defined using standardized segmentation and spectral unmixing. We observed a significantly higher density of CD14+CD11c+ monocyte-derived cells in ABMR versus TCMR (p = 0.011), and of cytotoxic CD3−PAX8−CD16+CD57+ NK cells in ABMR versus TCMR (p = 0.008), implicating both subsets in ABMR pathogenesis. Spatial clustering of these populations was evident in ABMR biopsies, suggesting organized immune infiltration. A logistic regression model combining both subsets yielded an area under the ROC curve of 0.79 (95% CI: 0.65–0.93), indicating moderate discriminatory power for ABMR. While Cox regression did not reveal statistically significant associations with graft survival, CD3−PAX8−CD16+CD57+ cells showed a trend toward increased risk (HR = 2.73, p = 0.09). These findings support a mechanistic role for monocyte and NK cell subsets in ABMR and demonstrate the utility of OPAL mIF for high-resolution immune profiling in human allografts. Our study advances understanding of cellular immune contributors to ABMR and highlights the potential diagnostic value of intragraft mononuclear cell phenotyping.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft RejectionKidney TransplantationFluorescent Antibody TechniqueLeukocytes, MononuclearHumansMaleFemaleMiddle AgedAdultRetrospective StudiesKiller Cells, NaturalAllograftsAgedMonocytesT-Lymphocytes

Stichwörter der Autor:innen

T-cell-mediated rejection (TCMR)antibody-mediated rejection (ABMR)kidney transplantationmultiplex immunofluorescence (OPAL)

Autor:innen und Institutionen

  • Department of Surgery, Korle Bu Teaching Hospital, Accra P.O. Box KB-77, Ghana.
  • Division of Kidney and Pancreas Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea.
  • Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea.
  • Asan Institute for Life Sciences, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea.

ORCID-Profile: Heounjeong Go, Hyunwook Kwon

Förderung

  • Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea
  • Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea

Zitieren

APA

Adjepong-Tandoh, E. K., Kim, J. M., Kwon, H. E., Ko, Y., Jung, J. H., Kim, Y. H., Go, H., Cho, H., Kim, S. Y., Ryu, Y. M., Shin, S., & Kwon, H. (2025). Multiplex Immunofluorescence Assay with Opal Reagents for Identifying Mononuclear Cell Subsets in Kidney Allograft Rejection Types. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311569

Vancouver

Adjepong-Tandoh EK, Kim JM, Kwon HE, Ko Y, Jung JH, Kim YH, et al. Multiplex Immunofluorescence Assay with Opal Reagents for Identifying Mononuclear Cell Subsets in Kidney Allograft Rejection Types. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311569

BibTeX
@article{AdjepongTandoh2025,
  author = {Adjepong-Tandoh, Ernest Kwame and Kim, Jin-Myung and Kwon, Hye Eun and Ko, Youngmin and Jung, Joo Hee and Kim, Young Hoon and Go, Heounjeong and Cho, Haeyon and Kim, Sang-Yeob and Ryu, Yeon-Mi and Shin, Sung and Kwon, Hyunwook},
  title = {Multiplex Immunofluorescence Assay with Opal Reagents for Identifying Mononuclear Cell Subsets in Kidney Allograft Rejection Types},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311569}
}
Kostenlos starten →